Colgate-Palmolive (NYSE:CL) Stock Price Expected to Rise, Barclays Analyst Says

Colgate-Palmolive (NYSE:CL - Get Free Report) had its price objective raised by equities researchers at Barclays from $83.00 to $89.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's price objective suggests a potential downside of 4.86% from the company's previous close.

Other equities research analysts have also recently issued research reports about the stock. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. StockNews.com downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a report on Tuesday, January 7th. Raymond James reiterated an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, Royal Bank of Canada restated a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus target price of $101.78.

Colgate-Palmolive Stock Performance

CL traded up $0.73 on Thursday, reaching $93.55. The company had a trading volume of 2,123,828 shares, compared to its average volume of 4,478,478. The stock has a market cap of $75.92 billion, a P/E ratio of 26.60, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company's fifty day moving average is $89.69 and its 200 day moving average is $93.52.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company earned $0.87 EPS. As a group, analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has authorized a share repurchase program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 6.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's board believes its stock is undervalued.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $26,000. Centricity Wealth Management LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $27,000. Vermillion Wealth Management Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $31,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $32,000. Finally, Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive in the 4th quarter valued at approximately $32,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.